Evidence map›Paper›PMID 42014055›Full record

ArticleOrthopaedic surgery2026

Impact of Infection Timing on Outcomes: A Comparative Study of Periprosthetic Joint and Fracture-Related Infections.

Lena Schwake, Jasper Frese, Arndt-Peter Schulz, Sidney Schaeffer, Ulf-Joachim Gerlach, Cornelius Grimme

Abstract readComparative Study
In one paragraph

Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lena SchwakeSection of Medicine, Universität zu Lübeck, Lübeck, Germany.ORCID https://orcid.org/0009-0001-8113-6289
Jasper FreseDepartment of Septic Bone and Joint Surgery, BG Klinikum Hamburg, Hamburg, Germany.
Arndt-Peter SchulzCenter for Clinical Research, BG Klinikum Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0002-4927-549X
Sidney SchaefferCenter for Clinical Research, BG Klinikum Hamburg, Hamburg, Germany.
Ulf-Joachim GerlachDepartment of Septic Bone and Joint Surgery, BG Klinikum Hamburg, Hamburg, Germany.
Cornelius GrimmeDepartment of Septic Bone and Joint Surgery, BG Klinikum Hamburg, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveImplant-associated infections, including periprosthetic joint infection (PJI) and fracture-related infection (FRI), are among the most challenging complications in orthopedic surgery. Although infection timing (early, delayed, late) is recognized as an important factor in surgical success, its impact on patient-reported outcomes and length of hospital stay has rarely been compared between PJI and FRI in a single cohort. This study aimed to examine the association between infection timing and health-related quality of life (HRQoL) as well as length of hospital stay (LOS), and to explore potential differences between PJI and FRI.

methodsWe conducted a retrospective monocentric cohort study of 60 patients with microbiologically confirmed implant-associated infections treated at a German level-I trauma center between January and December 2021, with follow-up performed in 2023. Patients with PJI (n = 29) or FRI (n = 31) were stratified as early (< 3 months), delayed (3-24 months), or late (> 24 months) to enable direct comparison between infection entities. Outcomes included EQ-VAS, EQ-5D-3L mean domain scores, LOS, reinfection, revision surgery, amputation, and in-hospital mortality. Group differences were tested using independent-samples t-tests for continuous variables and chi-square or Fisher's exact tests for categorical variables, with subgroup analyses considered exploratory due to small sample sizes.

resultsOf the 60 patients, 25 had early (PJI n = 11; FRI n = 14), 24 delayed (PJI n = 11; FRI n = 13), and 11 late infections (PJI n = 7; FRI n = 4). EQ-VAS was higher in FRI compared with PJI in early (63.4 ± 17.8, n = 13 vs. 48.3 ± 20.8, n = 9) and delayed infections (66.2 ± 16.8, n = 11 vs. 56.6 ± 13.5, n = 10), while both groups showed markedly lower EQ-VAS values in late infections (FRI: 39.7 ± 25.9, n = 3 vs. PJI: 43.3 ± 23.4, n = 6), which were analyzed descriptively due to very small subgroup sizes. The EQ-5D-3L mean domain score was lower (indicating better health status) in early FRI (1.55 ± 0.33, n = 12) than in early PJI (1.91 ± 0.39, n = 9) in unadjusted analyses. LOS increased with timing, particularly in PJI (early 39.6 ± 26.8 vs. 31.4 ± 29.0 days; delayed 100.6 ± 82.2 vs. 28.2 ± 10.2; p = 0.015). Reinfection rates increased with later timing (early: 6/11 PJI vs. 3/14 FRI; delayed: 8/11 vs. 8/13; late: 5/7 vs. 4/4). Revision surgery was more frequent in early PJI (7/11 vs. 4/14; p = 0.080) but was significantly more common in delayed FRI (12/13 vs. 6/11; p = 0.033). Amputation (≤ 9%) and in-hospital mortality (≤ 15%) were rare and showed no significant differences.

conclusionsInfection timing was associated with both clinical and patient-reported outcomes in implant-associated infections. Later infections were associated with poorer HRQoL, longer hospital stays, and higher reinfection rates, based on unadjusted analyses, with distinct patterns between PJI and FRI. Early recognition and timely, stage-adapted treatment strategies may help improve patient outcomes.

Indexed as

Periprosthetic FracturesProsthesis-Related InfectionsAgedAged, 80 and overFemaleHumansLength of StayMaleMiddle AgedQuality of LifeReoperationRetrospective StudiesTime Factorsfracture‐related infectionperiprosthetic joint infectionquality of lifetime factorstreatment outcome

Identifiers

PMID42014055
PMCPMC13238746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.